Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Etem, Caliskan"'
Autor:
Etem Caliskan, Martin Misfeld, Sigrid Sandner, Andreas Böning, Jose Aramendi, Sacha P. Salzberg, Yeong-Hoon Choi, Louis P. Perrault, Ilker Tekin, Gregorio P. Cuerpo, Jose Lopez-Menendez, Luca P. Weltert, Johannes Böhm, Markus Krane, José M. González-Santos, Juan-Carlos Tellez, Tomas Holubec, Enrico Ferrari, Gheorghe Doros, Maximilian Y. Emmert
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionAlthough cardiovascular surgery societies in Europe and the USA constantly strive for the exchange of knowledge and best practices in coronary artery bypass grafting (CABG), the available evidence on whether such efforts result in similar
Externí odkaz:
https://doaj.org/article/845924c927f1458985d994aec90ef407
Autor:
Maximilian Y. Emmert, Johannes Bonatti, Etem Caliskan, Mario Gaudino, Martin Grabenwöger, Martin T. Grapow, Paul Phillip Heinisch, Teresa Kieser-Prieur, Ki-Bong Kim, Attila Kiss, Fatima Mouriquhe, Markus Mach, Adrianna Margariti, John Pepper, Louis P. Perrault, Bruno K. Podesser, John Puskas, David P. Taggart, Om P. Yadava, Bernhard Winkler
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Coronary artery bypass grafting (CABG) is and continues to be the preferred revascularization strategy in patients with multivessel disease. Graft selection has been shown to influence the outcomes following CABG. During the last almost 60 years saph
Externí odkaz:
https://doaj.org/article/2fd045b771864dc3a3ea8704700230bd
Autor:
Maximilian Y. Emmert, Michael S. Firstenberg, Arthur T. Martella, Liming Lau, Stephen Zlock, Ashik Mohan, Taylor Spangler, Sarah Currie, Sacha P. Salzberg, Etem Caliskan
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 15, Iss 1, Pp 1-12 (2020)
Abstract Background Left atrial appendage occlusion (LAAO) represents a treatment alternative to anticoagulation in patients with atrial fibrillation. We evaluate a novel device for epicardial LAAO in a translational canine model. Methods Nine hounds
Externí odkaz:
https://doaj.org/article/e2bb5baabb25477d8a04fe5d49b8a50d
Autor:
Emanuela S. Fioretta, PhD, Valentina Lintas, PhD, Anna Mallone, PhD, Sarah E. Motta, PhD, Lisa von Boehmer, DVM, Petra E. Dijkman, PhD, Nikola Cesarovic, DVM, PhD, Etem Caliskan, MD, Héctor Rodriguez Cetina Biefer, MD, Miriam Lipiski, DVM, Mareike Sauer, DVM, Matilde Putti, PhD, Henk M. Janssen, PhD, Serge H. Söntjens, PhD, Anthal I.P.M. Smits, PhD, Carlijn V.C. Bouten, PhD, Maximilian Y. Emmert, MD, PhD, Simon P. Hoerstrup, MD, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 5, Iss 1, Pp 15-31 (2020)
Summary: This study showed that bone marrow mononuclear cell pre-seeding had detrimental effects on functionality and in situ remodeling of bioresorbable bisurea-modified polycarbonate (PC-BU)-based tissue-engineered heart valves (TEHVs) used as tran
Externí odkaz:
https://doaj.org/article/d9fb23707ad04e9787c2469547a87f18
Autor:
Etem Caliskan, Sigrid Sandner, Martin Misfeld, Jose Aramendi, Sacha P. Salzberg, Yeong-Hoon Choi, Vilas Satishchandran, Geeta Iyer, Louis P. Perrault, Andreas Böning, Maximilian Y. Emmert
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Background Vein graft disease (VGD) impairs graft patency rates and long-term outcomes after coronary artery bypass grafting (CABG). DuraGraft is a novel endothelial-damage inhibitor developed to efficiently protect the structural and functi
Externí odkaz:
https://doaj.org/article/2fa6e6dcc1634138b57e227747b430a8
Autor:
Etem Caliskan, Florian Fischer, Felix Schoenrath, Maximilian Y. Emmert, Francesco Maisano, Volkmar Falk, Christoph T. Starck, Tomas Holubec
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 12, Iss 1, Pp 1-5 (2017)
Abstract Background We retrospectively assessed two types of sutureless screw-in left ventricular (LV) leads (steroid eluting vs. non-steroid eluting) in cardiac resynchronization therapy (CRT) implantation with regards to their electrical performanc
Externí odkaz:
https://doaj.org/article/d2a4d77de8494e6ab5395147098eba6c
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 15, Iss 1, Pp 1-2 (2020)
Externí odkaz:
https://doaj.org/article/7e2283f094d145bc9b4641f2f6875987
Autor:
Mirko Doss, Maximilian Vondran, Henning Warnecke, Taoufik Ouarrak, Etem Caliskan, M. Albert, Tamer Ghazy, Andreas Liebold, Ardawan Rastan, Jochen Senges, Edgar Eszlari, Nicolas Doll, Thorsten Hanke
Publikováno v:
The Heart Surgery Forum. 24:E785-E793
Background: Despite excellent data on lowering long-term stroke and all-cause mortality rates, currently, only 25–40% of atrial fibrillation (AF) patients undergo simultaneous surgical ablation therapy (SA) during cardiac surgery. Surgeon’s fear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8649a7a9d6378df96920e03bf21f8ca
https://doi.org/10.1532/hsf.3995
https://doi.org/10.1532/hsf.3995
Autor:
Sigrid Sandner, Catherine J Pachuk, Etem Caliskan, Maximilian Y. Emmert, Thomas Aschacher, Milan Milojevic
Publikováno v:
Minerva Cardioangiologica, 68(5), 480-488. Edizioni Minerva Medica
The saphenous vein graft (SVG) remains the most commonly used conduit in coronary artery bypass grafting (CABG). In light of this further research must be aimed at the development of strategies to optimize SVG patency and thereby improve both short-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f58d5e1000408a0f0804d0b935ec508
https://doi.org/10.23736/s0026-4725.20.05234-2
https://doi.org/10.23736/s0026-4725.20.05234-2
Autor:
Etem, Caliskan, Martin, Misfeld, Sigrid, Sandner, Andreas, Böning, Jose, Aramendi, Sacha P, Salzberg, Yeong-Hoon, Choi, Louis P, Perrault, Ilker, Tekin, Gregorio P, Cuerpo, Jose, Lopez-Menendez, Luca P, Weltert, Johannes, Böhm, Markus, Krane, José M, González-Santos, Juan-Carlos, Tellez, Tomas, Holubec, Enrico, Ferrari, Maximilian Y, Emmert, George, Gradinariu
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 62(4)
OBJECTIVES Left main coronary artery disease (LMCAD) is considered an independent risk factor for clinical events after coronary artery bypass grafting (CABG). We have conducted a subgroup analysis of the multicentre European DuraGraft Registry to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955a2cd0cff8a63d7aa7016b6a25c36e
https://pubmed.ncbi.nlm.nih.gov/36099029
https://pubmed.ncbi.nlm.nih.gov/36099029